1 / 25

From Lecture Hall to Production Floor Academia Industry Ramot at Tel Aviv University Ltd. Present

From Lecture Hall to Production Floor Academia Industry Ramot at Tel Aviv University Ltd. Presented by Larry Loev. Academia – Common Myths. Research is not applicable to the real world University personnel don’t understand industry time frames

hali
Download Presentation

From Lecture Hall to Production Floor Academia Industry Ramot at Tel Aviv University Ltd. Present

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. From Lecture Hall to Production Floor Academia Industry Ramot at Tel Aviv University Ltd. Presented by Larry Loev

  2. Academia – Common Myths • Research is not applicable to the real world • University personnel don’t understand industry time frames • Industrial standards can’t be maintained • The urge to publish damages confidentiality

  3. Why Academia? • Top researchers • Peer reviewed technology • Lab facilities • “Cross-fertilization” • Technologies with wide applications • IP vigorously protected

  4. Challenge: Contrasting Cultures University Social responsibilities Pure scientific driven research Create new knowledge Corporate Shareholders responsibilities Specific objectives, product focused Develop new products Applied research Ownership & secrecy Control of material Basic research Publications & collaborations Sharing of material

  5. The Facilitator The University Tech Transfer Office

  6. Case Study: Ramot at TAU • Ramot Objectives To foster, initiate and lead the transfer of new technologies from the laboratory to the marketplace To strengthen the relationship between University research community and the business community

  7. Ramot - Board of Directors • Industry, Venture Capital, Law • Mr. Dov Lautman, Chairman of Delta Galil Industries • Dr. David Haselkorn, former president of Clal Biotechnologies • Mr. Moshe (Mori) Arkin, Vice Chairman of Perrigo • Mr. Hemi Peres, GP, Pitango Venture Capital • Mr. Shmaryahu Shapiro, CEO, Technorov holdings • Ms. Tally Eitan, Adv., Eitan Law Group • University leadership & scientists • Professor Hagit Messer-Yaron, Ramot Chairperson,VP Research & Development • Professor Zvi Galil, President • Mr. Mordehai Kohn, Director General • Professor Dany Leviatan, Rector • Professor Yair Aharonovitz, • Professor Yoel Kloog, Dean, Faculty of Life Sciences

  8. Tech Transfer Process Patenting & Marketing Strategy Discovery & Innovation Follow Up on Contract Business Development Evaluation Revenues Academic Basic and Applied Research

  9. Ramot Organization • Business Development • Engineering, Computer Science, Exact Sciences • Life sciences • Medical devices • IP management • Legal

  10. Bridging the Development Gap • A Development Gap lies between discovery and commercialization • Required: applied research, first prototype stage • Looks like a product, performs certain specs • Solution: feasibility research • Sponsored by target licensee • Sponsored by special funds (Ramot Fund, Partnership, etc.)

  11. Deal Models Research and Development Agreements Funded by companies, Israeli government Licensing Deals Licensing of IP, know how to an existing company New venture formation / Spin-offs Licensing of IP to the start-up company • Research Funds • Fees and Milestones payments • Running Royalties • Equity participation

  12. “Lines in the Sand” • IP - the heart and soul of a University’s property • Product Diligence – Responsibility to the public

  13. Established 1956 • 9 faculties, 24 schools, 105 departments • over 100 research institutes • 30,000 students, 1,800 of them are doctorate students • 2,200 faculty members About Tel Aviv University Research Highlights • Life sciences (120 researchers(Medicine (130 researchers(Exact sciences (240 researchers(Engineering (110 researchers) • 600 researchers are affiliated with the main medical centers in greater Tel Aviv area Tel Aviv University

  14. Thank You Larry Loev Manager Business Development, Engineering and Physical Sciences Larry.loev@ramot.org www.ramot.org

  15. Extra Slides

  16. Development Gap Industry Requirements A prototype, Looks like a product, performs certain specs Pre-clinical results , efficacy in animal models, Toxicology • funding • Potential licensee point of view(answer the right questions…) • Funding of Research by target licensee under an R&L/R&O agreement • Funding of Research by special funds: Stringent screening process based on both commercial and scientific criteria. Plan, Budget & Milestones Stringent monitoring of the process.

  17. Bridging the Gap (I) • Philanthropic funds • Tel Aviv University Fund for Applied Research* • The Colton Family Next Generation Technologies Institute • “TAU Fund for Applied Research” supports 7-10 projects per year, $3M in 2003-6 • Projects are selected following a stringent process by Ramot and a professional committee, to meet commercial as well as scientific criteria • “The Colton Fund” - Matching funds by Johnson & Johnson * Funded by the Yeshaya Horowitz Association , Jerusalem

  18. Bridging the Gap (II) • A corporate partner allocates an annual amount to support of research in pre-defined areas of interest. • The fund solicits highly promising projects with IP position, development plan and clearly defined commercialization path • A joint steering committee of the corporate partner, TAU and Ramot evaluated and selects projects • Ramot provides strategic and scientific guidance with a clear market focus • The corporate partner has certain rights in the IP generated in the research • Two such multi-million dollar funds are currently operational: nano-technology and smart-cards

  19. Bridging the Gap (III)TAU-Tech TAU Future Technology Partnership (TAU-Tech) Return on investment investment $8.5M Ramot: Technology management Business development Technology transfer Industry Licensing: royalties and fees Start-ups: Equity participation Tel Aviv University technologies

  20. TAU-Tech Projects Biotechnology • Drug candidates for Alzheimer’s Disease • Drug candidates for type II diabetes • Novel cancer targeted drug delivery system Medical Devices • Direct lung fluid monitoring system for congestive heart failure patients in Clinical Trials • Optical Micro-Biosensors for Biomedical Diagnosis Energy & Electronics • Fuel cells for mobile electronics and industrial applications • Micro-battery on a chip

  21. Alzheimer’s Mouthwash Schizophrenia Proof of concept Product Drug Candidate R&L (Israel) R&L (BioLineRx) R&L (UK) • Lead compound • Pre-clinical package Product 20% UK market share Phase II – Q4 ‘07 Commercialization paths IP Protection & Commercialization Strategy:License TAU Fund TAU Tech R&L

  22. Pipeline – Bio/Pharma

  23. Pipeline (II) Diagnostic, medical devices and agro pipeline Engineering / exact sciences pipeline

  24. Pharmaceuticals/Biotechnology Cardiovascular & Angiogenesis Alzheimer’s Disease Amyloid Diseases Cancer CNS Diabetes Drug Delivery Onychomycosis Stem Cell Therapy Virology Diagnostics Liver Diseases Medical Devices Lung fluid monitoring Drug delivery Continuous non-invasive blood pressure monitoring Magnetic resonance imaging of macromolecules and connective tissue Advanced Echocardiography Current Available Bio-Medical Technologies

  25. TAU and Ramot Links TAU Research Catalog:www.tau.ac.il Research Research Catalog Ramot Available Technologies: www.ramot.org Available Technologies

More Related